BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Latanoprostene Bunod | Latanoproste bunod is a nitric oxide-donating prostaglandin F2α (FP) receptor agonist. Under the trade name Vyzulta, it has been approved for the treatment of intraocular pressure in patients with open-angle glaucoma or ocular hypertension in 2017. Group: Pharmaceutical. CAS No. 860005-21-6. Pack Sizes: 25 mg. Product ID: B2692-291720. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Latanoprost Impurities | Latanoprost Impurities are critical reference standards used in the quality control and development of ophthalmic drugs for managing glaucoma. They play a key role in ensuring the safety and efficacy of latanoprost formulations by helping identify and quantify impurities that might affect performance or patient outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lathosterol | Lathosterol is an intermediate in the biosynthesis of cholesterol. Lathosterol in serum is carried on lipoproteins and is indicative of the rate of cholesterol synthesis. It acts as a marker of synthesis of cholesterol and is not affected by dietary consumption of cholesterol. Group: Pharmaceutical. CAS No. 80-99-9. Pack Sizes: 1 g. Product ID: B1370-033919. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Latinone | Latinone, a member of the macrolide antibiotic class, is a highly effective drug that promptly halts the propagation and procreates curtailment in various types of bacterial infections occurring in the urinary tract, skin, and pneumonia. This striking agent is contraindicated in viral disorders and should only be administered for bacterial infections. Group: Pharmaceutical. CAS No. 79157-36-1. Pack Sizes: 1 mg. Product ID: NP4464. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Laurifoline | Laurifoline isolated from the herbs of Lindera aggregata. Uses: Anti-hbv activities. Group: Pharmaceutical. CAS No. 7224-61-5. Pack Sizes: 1 mg. Product ID: NP0750. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lavendustin A | Lavendustin A is an epidermal growth factor receptor inhibitor tyrosine kinase with IC50 value of 11 nM. Group: Pharmaceutical. CAS No. 125697-92-9. Pack Sizes: 10 mg. Product ID: B0084-047820. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LB-100 | LB-100 is a water-soluble protein phosphatase 2A (PP2A) inhibitor (IC50 = 0.85 μM and 3.87 μM in BxPc-3 and Panc-1 cells) that enhanced the effects of sorafenib in HCC cells only during hypoxic environments. Group: Pharmaceutical. CAS No. 1632032-53-1. Pack Sizes: 100 mg. Product ID: B1370-474642. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Biopterin | L-Biopterin is an oxidation product from the melanogenesis regulating cofactor (6R)5,6,7,8 tetrahydrobiopterin (6-BH4). It is an important cofactor in the production of many essential neurotransmitters, such as dopamine, seratonin and epinephrine, and plays an important role in the production of nitric oxide in the body. It has been shown to be cytotoxic to melanocytes in vitro, and may be a useful noninvasive biomarker. Group: Pharmaceutical. CAS No. 22150-76-1. Pack Sizes: 1 g. Product ID: B0084-467547. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Carnitine | L-carnitine is a constituent striated muscle and liver, and also a cofactor involved in fatty acid metabolism for transporting fatty acids through the inner mitochondrial membrane. It also acts as an inhibitor of HDAC. Nutritional supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 541-15-1. Pack Sizes: 50 g. Product ID: BAT-008091. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Carnosine | L-Carnosine is a dipeptide concentrated in muscle and brain tissue. It acts as an antioxidant that scavenges reactive oxygen species (ROS) and transition metal ions. It is also a neurotransmitter in the brain. L-Carnosine has potential antioxidant and anti-glycosylation activities, preventing acetaldehyde-induced non-enzymatic glycosylation and protein coupling. It is also a substrate for carnosinase detection, which can maintain pH balance in the body and extend cell life. Group: Pharmaceutical. CAS No. 305-84-0. Pack Sizes: 100 g. Product ID: BAT-008152. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LCKLSL acetate | LCKLSL acetate is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-447444. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LCL-161 | LCL161 is an orally bioavailable second mitochondrial-derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins, with potential antineoplastic activity. SMAC mimetic LCL161 binds to IAPs, such as X chromosome-linked IAP (XIAP) and cellular IAPs 1 and 2. Since IAPs shield cancer cells from the apoptosis process, this agent may restore and promote the induction of apoptosis through apoptotic signaling pathways in cancer cells. IAPs are overexpressed by many cancer cell types and suppress apoptosis by binding and inhibiting active caspases-3, -7 and -9, which play essential roles in apoptosis (programmed cell death), necrosis and inflammation. Group: Pharmaceutical. CAS No. 1005342-46-0. Pack Sizes: 25 mg. Product ID: B0084-462558. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LCS3 | LCS3 is a reversible inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50 of 3.3 μM and 3.8 μM, respectively. Group: Pharmaceutical. CAS No. 109844-92-0. Pack Sizes: 50 mg. Product ID: B1370-185021. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Cystine dimethyl ester dihydrochloride | L-Cystine dimethyl ester dihydrochloride serves as an efficacious antioxidant, exhibiting commendable immunomodulatory, metabolic and cytoprotective potential. Its application is extended towards abating oxidative stress, addressing cardiovascular complications, and counteracting hepatic insult instigated by noxious agents. In essence, this compound offers a multifaceted therapeutic approach to sustain homeostatic balance in cellular milieu. Group: Pharmaceutical. CAS No. 32854-09-4. Pack Sizes: 100 g. Product ID: BAT-015046. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LDC1267 | LDC1267 is a highly selective TAM kinase inhibitor with IC50 of <5 nM, 8 nM, and 29 nM for Mer, Tyro3, and Axl, respectively. Displays lower activity against Met, Aurora B, Lck, Src, and CDK8. Group: Pharmaceutical. CAS No. 1361030-48-9. Pack Sizes: 50 mg. Product ID: B0084-463399. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LDCA | LDCA is a dual-hit metabolic modulator and inhibits LDH-A enzyme activity to stimulate apoptosis in the malignant population. LDCA can be used for the research of oncogenic progression. Group: Pharmaceutical. CAS No. 349106-80-5. Pack Sizes: 25 mg. Product ID: B1370-257402. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LDN-193189 | LDN193189 is a selective and potent ALK inhibitor with potential anticancer activity. Uses: Differentiation. Group: Pharmaceutical. CAS No. 1062368-24-4. Pack Sizes: 50 mg. Product ID: B0084-307751. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LDN-193189 HCl | LDN193189 HCl is the hydrochloride salt of LDN193189, which is a selective BMP signaling inhibitor, and inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM, respectively. Group: Pharmaceutical. CAS No. 1062368-62-0. Pack Sizes: 10 mg. Product ID: B2693-456763. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LDN-212854 | LDN-212854 is a potent and selective BMP receptor inhibitor with IC50 of 1.3 nM for ALK2. LDN-212854 exhibits some selectivity for ALK2 in preference to other BMP type I receptors, ALK1 and ALK3, which may permit the interrogation of ALK2-mediated signaling, transcriptional activity, and function. LDN-212854 potently inhibits heterotopic ossification in an inducible transgenic mutant ALK2 mouse model of fibrodysplasia ossificans progressiva. Group: Pharmaceutical. CAS No. 1432597-26-6. Pack Sizes: 100 mg. Product ID: B2693-286416. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LDS 867 | LDS 867 is a potent and selective protein kinase D (PKD) inhibitor used in the biomedical industry for research on cancer treatment. It effectively inhibits PKD and displays anticancer activity against a range of malignancies, including breast and pancreatic cancers. LDS 867 is a valuable tool in the study of PKD signaling pathways and potential therapeutic strategies for various diseases. Group: Pharmaceutical. CAS No. 106025-71-2. Pack Sizes: 250 mg. Product ID: B2708-285552. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lecithin Hydrogenated | Lecithin Hydrogenated is a phosphocholine with palmitic acid at the sn-1 position and stearic acid at the sn-2 position. It can be used in formulation of micelles, liposomes, and other types of artificial membranes. Lecithin Hydrogenated is an emulsifier used in cosmetics and also acts as a penetration enhancer. Group: Pharmaceutical. CAS No. 92128-87-5. Pack Sizes: 25 g. Product ID: B2697-045173. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ledipasvir acetone | Ledipasvir is an inhibitor of hepatitis C virus NS5A. Group: Pharmaceutical. CAS No. 1441674-54-9. Pack Sizes: 50 mg. Product ID: B0084-463250. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ledipasvir Impurities | Ledipasvir Impurities, integral constituents in the biomedical domain, are fundamental in developing and validating analytical methodologies. Their crucial function ensures the purity, efficacy, and safety of Ledipasvir, vital for combating chronic hepatitis C, thereby strengthening the framework of therapeutic approaches in virological medicine. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LEE011 succinate | LEE011 is an orally bioavailable and highly specific CDK4/6 (cyclin-dependent kinase 4/6) inhibitor. LEE011 in combination with LGX818 (a V600E BRAF specific inhibitor) or BYL719 (a PIK3CA specific inhibitor) leads to robust anti-tumor activity in melanoma and breast cancer tumor models. Group: Pharmaceutical. CAS No. 1374639-75-4. Pack Sizes: 1 g. Product ID: B2693-463203. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leflunomide Impurities | Leflunomide Impurities are critical components in the meticulous quality assurance and stability evaluations of Leflunomide, a widely used therapeutic for rheumatoid and psoriatic arthritis. They elucidate degradation mechanisms and fortify the assurance of safety and effectiveness, thereby elevating the reliability of this immunosuppressive drug in pharmaceutical sciences. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lehmbachol D | Lehmbachol D is a natural compound, aidng in the research of skin infections and inflammatory maladies. Group: Pharmaceutical. CAS No. 913556-40-8. Pack Sizes: 1 mg. Product ID: NP5071. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lemongrass oil | Lemongrass oil is an essential oil extracted from lemongrass. It has anti-frustration, antibacterial, sterilizing, deodorizing, mold killing, insect killing and disease prevention effects. And it can be used in the preparation of daily essentials such as hand sanitizer and body wash. Lemongrass has digestion and cures colds, builds the stomach and regulates the intestines to help digestion, and is quite suitable for drinking after meals. Uses: Room fragrance, massage oil, soap, shampoo, shower gel. Group: Pharmaceutical. CAS No. 8007-2-1. Pack Sizes: 1 kg. Product ID: B1370-185301. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lenalidomide | Cereblon binder; induces ubiquitination and degradation of CK1a and transcription factors IKZF1, IKZF3 and SALL4 by E3 ubiquitin ligase. Group: Pharmaceutical. CAS No. 191732-72-6. Pack Sizes: 25 g. Product ID: NP3322. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lenalidomide Impurities | Lenalidomide Impurities are crucial in the pharmaceutical analysis and quality control of lenalidomide, a drug primarily used for treating multiple myeloma and myelodysplastic syndromes. Understanding these impurities aids in refining the production process, ensuring the efficacy and safety of lenalidomide for clinical applications in oncology. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lenalidomide Impurity B | An impurity of Lenalidomide, a medication used for the treatment of myelodysplastic syndrome (MDS), multiple myeloma, and mantle cell lymphoma (MCL). Group: Pharmaceutical. CAS No. 827026-45-9. Pack Sizes: 10 g. Product ID: B2694-078025. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lenvatinib | Lenvatinib (E7080) is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM, less potent against VEGFR1/Flt-1, ~10-fold more selective for VEGFR2/3 against FGFR1, PDGFRα/&beta. Group: Pharmaceutical. CAS No. 417716-92-8. Pack Sizes: 500 mg. Product ID: B0084-092131. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lenvatinib Impurities | Lenvatinib Impurities, integral to the pharmaceutical sector, play a crucial role in ascertaining Lenvatinib's quality and potency through meticulous identification and quantification of trace constituents. As a tyrosine kinase inhibitor, Lenvatinib targets thyroid, renal, and hepatocellular carcinomas, with impurity surveillance bolstering drug safety and adherence to regulatory mandates. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lepirudin | Lepirudin is an anticoagulant that acts as a direct thrombin inhibitor. Lepirudin binds to both free and clot-bound thrombin. Lepirudin is approved for the treatment of heparin-induced thrombocytopenia (HIT). Uses: The treatment of heparin-induced thrombocytopenia (hit). Group: Pharmaceutical. CAS No. 138068-37-8. Pack Sizes: 1 mg. Product ID: BAT-010047. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leptin (22-56), human | Leptin (22-56) (human) is the fragment of leptin, a hormone produced by the fat cells in human body. Group: Pharmaceutical. CAS No. 183598-56-3. Pack Sizes: 1 mg. Product ID: BAT-006180. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leptin (human) | Leptin (human) is a peptide hormone secreted from white adipocytes and implicated in the regulation of food intake and energy balance. Group: Pharmaceutical. CAS No. 177404-21-6. Pack Sizes: 5 mg. Product ID: BAT-015269. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leq-506 Impurities | Leq-506 Impurities are critical in the biomedical industry for understanding the chemical profile and stability of Leq-506, a promising investigational drug for chronic myeloid leukemia (CML) treatment. These impurities aid in refining synthesis processes and ensuring drug efficacy and safety, enhancing therapeutic applications for leukemia patients. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lercanidipine Hydrochloride | A dihydropyridine calcium channel blocker. Antihypertensive. Uses: The hydrochloride salt form of lercanidipine could be used as an antihypertensive agent through influencing the l-type ca2+ channel at some extent. Group: Pharmaceutical. CAS No. 132866-11-6. Pack Sizes: 2 g. Product ID: B2692-311627. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lercanidipine Impurities | Lercanidipine Impurities hold crucial significance in pharmaceutical realms, facilitating both synthesis and quality assurance of the calcium channel antagonist, Lercanidipine. These impurities are pivotal for hypertension treatment, ensuring the drug's efficacy and safety, thereby advancing therapeutic practices within cardiovascular health management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-(+)-Ergothioneine | L-(+)-Ergothioneine is a natural amino acid isolated from the rye ergot fungus and later identified in rat erythrocytes and the liver. L-(+)-Ergothioneine is an antioxidant and a unique cell physiological protective agent, which has many physiological functions such as scavenging free radicals, whitening, anti-aging, preventing ultraviolet radiation damage, maintaining DNA synthesis and normal cell growth. Group: Pharmaceutical. CAS No. 497-30-3. Pack Sizes: 500 mg. Product ID: BBF-03773. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-(+)-Ergothioneine-[d3] | L-(+)-Ergothioneine-[d3] is a stable isotope analogue of L-(+)-Ergothioneine. It is a natural molecule isolated from the rye ergot fungus and later identified in rat erythrocytes and liver and in numerous other animal tissues. Its antioxidizing properties may afford the compound therapeutic potential or it may be used as a food additive or in cosmetics. Group: Pharmaceutical. CAS No. 1356933-89-5. Pack Sizes: 10 mg. Product ID: BLP-005797. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lesinurad | Lesinurad(RDEA594), once-daily inhibitor of URAT1, is a transporter in the kidney that regulates uric acid excretion from the body. Group: Pharmaceutical. CAS No. 878672-00-5. Pack Sizes: 1 g. Product ID: B0084-460174. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lesinurad Impurities | Lesinurad Impurities are critical reference standards in the pharmaceutical industry for ensuring the purity and safety of lesinurad, a medication used to manage hyperuricemia in gout patients. These impurities help optimize the drug synthesis process, ensuring therapeutic efficacy and addressing potential safety concerns associated with lesinurad treatment. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lesinurad Impurity 16 | An intermediate of Lesinurad, a urate transporter inhibitor used for the treatment of high blood uric acid levels associated with gout. Group: Pharmaceutical. CAS No. 878671-99-9. Pack Sizes: 1 g. Product ID: B2694-473688. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Letermovir | Letermovir is a novel anti-CMV compound which targets the pUL56 (amino acid 230-370) subunit of the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors. It has a novel mode of action targets the enzyme UL56 terminase and keep active to other drug-resistant virus. It has been approved in prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). Uses: Antiviral agents. Group: Pharmaceutical. CAS No. 917389-32-3. Pack Sizes: 5 mg. Product ID: B2693-460490. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Letrozole Impurities | Letrozole Impurities are crucial in the biomedical field for assessing the purity and stability of the drug Letrozole, used in the treatment of hormone receptor-positive breast cancer. These impurities aid in research to improve drug formulations and ensure their therapeutic efficacy, serving as benchmarks for quality control in pharmaceutical development. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| [Leu15]-Gastrin I (human) | A derivative of Gastrin I (human), an endogenous peptide produced by stomach and it acts as a selective CCK2 receptor agonist. Group: Pharmaceutical. CAS No. 39024-57-2. Pack Sizes: 5 mg. Product ID: BAT-006204. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (+)-Leucocyanidin | Leucocyanidin is a natural compound extracted from Litchi Chinensis. Group: Pharmaceutical. CAS No. 69256-15-1. Pack Sizes: 5 mg. Product ID: B1370-335048. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leuconolam | Leuconolam comes from the herbs of Alstonia scholaris. Group: Pharmaceutical. CAS No. 93710-27-1. Pack Sizes: 1 mg. Product ID: NP0464. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leucosceptoside A | Leucosceptoside A is a natural compound isolated from the dried roots of Clerodendrum bungei. Group: Pharmaceutical. CAS No. 83529-62-8. Pack Sizes: 10 mg. Product ID: NP5354. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leucoside | Leucoside is a flavonoid isolated from the herbs of Aesculus L. Group: Pharmaceutical. CAS No. 27661-51-4. Pack Sizes: 20 mg. Product ID: NP1885. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leucoson Impurities | Leucoson Impurities, indispensable analytical benchmarks in the biomedical sector, play an essential role in the detection and quantification of contaminants throughout Leucoson production. This pharmaceutical is crucial for dermatological disorder management. These impurities ensure drug safety and efficacy, underpinning rigorous quality control and compliance with regulatory standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leucovorin Calcium | leucovorin calcium is an active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs. Leucovorin calcium counteracts the toxic effects of these medications, 'rescuing' the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug's metabolite to its target enzyme, thus prolonging drug activity. Group: Pharmaceutical. CAS No. 1492-18-8. Pack Sizes: 5 g. Product ID: B2693-301409. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Leu-Leu-Leu-OH | Leu-Leu-Leu-OH is a leucine derivative. Group: Pharmaceutical. CAS No. 10329-75-6. Pack Sizes: 5 g. Product ID: BAT-006518. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levalbuterol Impurities | Levalbuterol Impurities, crucial in pharmaceutical advancements, underpin the rigorous quality control of bronchodilator therapies for asthma and COPD. Their presence provides deep insights into the purity, stability, and therapeutic potential of levalbuterol formulations, thereby ensuring rigorous safety standards and bolstering respiratory health through comprehensive safety assurances. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levalbuterol tartrate | Levosalbutamol tartrate, the R-enantiomer of salbutamol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Uses: Used in the treatment of asthma and chronic obstructive pulmonary disease (copd). Group: Pharmaceutical. CAS No. 661464-94-4. Pack Sizes: 50 mg. Product ID: B1370-453721. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levamisole Impurities | Levamisole Impurities, critical in pharmaceutical quality control, enable comprehensive assessment of levamisole, a key anthelmintic combating parasitic infestations. These impurities are instrumental in verifying drug purity and potency, thus supporting secure and effective therapeutic protocols applicable in human and veterinary medicine, contributing substantially to health management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levamisole Impurity D (HCl salt form) | The hydrochloride of Levamisole Impurity D. Levamisole is a medication used for the treatment of parasitic worm infections. It was also indicated to be effective for colon cancer therapy in combination with fluorouracil. Group: Pharmaceutical. CAS No. 4335-29-9. Pack Sizes: 30 mg. Product ID: B1298-007230. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levetiracetam Carboxylic Acid | An impurity of Levetiracetam, a medication indicated for the treatment of epilepsy. Group: Pharmaceutical. CAS No. 102849-49-0. Pack Sizes: 50 mg. Product ID: B2694-053235. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levetiracetam EP Impurity B | Levetiracetam EP Impurity B is an impurity of Levetiracetam, a medication indicated for the treatment of epilepsy. Group: Pharmaceutical. CAS No. 358629-47-7. Pack Sizes: 50 mg. Product ID: B2694-473716. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levetiracetam EP Impurity D | the enantiomer to Levetiracetam. Group: Pharmaceutical. CAS No. 103765-01-1. Pack Sizes: 50 mg. Product ID: B0215-473717. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levetiracetam Impurities | Levetiracetam Impurities constitute an essential focus in biomedical inquiries, underpinning the assurance of antiepileptic medication safety and efficacy. Rigorous analysis aligns with regulatory mandates, facilitating the advancement of epilepsy therapies. Comprehensive impurity characterization is vital for optimizing pharmacological formulations and safeguarding patient health during therapeutic regimens. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levobetaxolol HCl | Levobetaxolol exhibits a higher affinity at cloned human β1 and β2 receptors with Ki value of 0.76 nM and 32.6 nM, respectively. Group: Pharmaceutical. CAS No. 116209-55-3. Pack Sizes: 1 g. Product ID: B2693-161367. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levocabastine Impurities | Levocabastine Impurities are critical in the biomedical field for the evaluation and quality control of levocabastine formulations. These impurities help identify degradation products and are essential in ensuring the drug's purity, efficacy, and safety in treating allergic rhinitis and conjunctivitis. They enable comprehensive analysis during the drug development process. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levocetirizine Impurities | Levocetirizine Impurities, byproducts in the synthesis of levocetirizine, play a crucial role in assessing the drug's quality and safety for treating allergic rhinitis and chronic urticaria. Their study aids in refining purification processes, ensuring therapeutic efficacy and compliance with regulatory standards in allergy management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levodopa | Levodopa is used as a cell adhesion molecule in serum-free cultures of anchorage-dependent mammalian cells! Keep container tightly closed in a dry and well-ventilated place. Uses: Antiparkinsonism. Group: Pharmaceutical. CAS No. 59-92-7. Pack Sizes: 500 g. Product ID: BAT-008090. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levofloxacin-007-S | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 2130840-90-1. Pack Sizes: 10 mg. Product ID: B2694-338769. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levofloxacin Impurities | Levofloxacin Impurities, crucial in the biomedical domain, underpin stringent quality assurance, refining formulations of the antibacterial Levofloxacin. These impurities are instrumental in validating the safety and therapeutic efficacy of Levofloxacin, widely utilized in addressing bacterial challenges such as pneumonia, urinary tract, and skin infections, thereby enhancing pharmacological interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levofloxacin Impurity 8-S | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 2130840-92-3. Pack Sizes: 10 mg. Product ID: B2694-338770. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levofloxacin N-oxide | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 117678-38-3. Pack Sizes: 50 mg. Product ID: B0185-473746. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levofloxacin Related Compound A | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 117707-40-1. Pack Sizes: 30 mg. Product ID: B0185-241663. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.